New Jersey A 973: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 973

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Conaway, Herb

View New Jersey A 973 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.